Filing Flows › Traws Pharma (TRAW) › Q1 2025 › vs Q1 2024
Traws Pharma (TRAW) Q1 2025 vs Q1 2024 (year over year)
Traws Pharma's revenue rose $1K (+2%) from $56K in Q1 2024 to $57K in Q1 2025.
Traws Pharma, Q1 2025: revenue $57K (+2% year over year), net earnings $21.5M, operating cash flow −$5.4M. The chart draws each line against Q1 2024, the increases inside each band.
Every line
| Line | Q1 2025 | Q1 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $57K | $56K | $1K | +2% |
| Other income, net | $26.7M | $229K | $26.5M | 117× |
| Costs & expenses | $26.8M | $5.3M | $21.5M | +408% |
| Operating costs | $5.3M | $5.3M | −$8K | -0.2% |
| Net earnings | $21.5M | −$5.0M | $26.5M | — |
| Research & development | $2.5M | $1.9M | $594K | +31% |
| General & admin | $2.8M | $3.4M | −$602K | -18% |
| Operating cash sources | $27.1M | −$222K | $27.3M | — |
| Depreciation & amortization | $1K | $4K | −$3K | -75% |
| Share-based compensation | $161K | $333K | −$172K | -52% |
| Cash used in operations | $5.4M | $4.4M | $1.0M | +23% |
| Working capital & other | $27.1M | −$222K | $27.3M | — |
Questions
How much did Traws Pharma's revenue grow year over year in Q1 2025?
Traws Pharma's revenue rose $1K (+2%) from $56K in Q1 2024 to $57K in Q1 2025.